Brought to you by 
DuPont buys CombiChem for $95mm cash in tender offer
19 May 2000
Executive Summary
To get itself a strong in-house unit to drive future product discovery efforts, DuPont Pharmaceuticals has agreed to buy computational drug discovery company CombiChem. Its tender offer of $95mm, or $6.75 per share, is a (pr)35% premium to the stock's 10-day average pre-announcement.
Deal Industry
- Pharmaceuticals
-
Biotechnology
-
Drug Discovery Tools
- Molecular Diversity
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
DuPont buys CombiChem for $95mm cash in tender offer
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice